Steep drop in breast cancer rates

Less hormone therapy plus less screening

USA - A steep drop in breast cancer rates between 2002 and 2003 correlates with the decline in hormone therapy use, according to research froma the American Cancer Society (ACS).

However, the researchers also point out that the decline might indicate that fewer instances were detected because mammogram screenings had levelled off. (Between 1980-98, when mammograms became more common, breast cancer rates rose fast and by almost 40%).

The greatest decline in rates was among women 50-69 years old – those most likely to receive hormone therapy. However, the researchers say that stopping hormone therapy cannot explain their other major finding: breast cancer rates started to drop in 1999, for all women 45 and above, well before the link between hormone therapy and health problems was discovered. They reason that the most likely explanation for this earlier decline is, after almost 12 years of increase, mammography use levelled off during those years. 

The ACS also believes that part of the decline in breast cancer cases might be temporary, which would mean there has been a delay in detection, rather than an actual decrease in incidence.

20.06.2007

Read all latest stories

Related articles

Photo

Article • Patient front and centre

One-Stop Clinic: diagnosis and treatment in one day, on one site, by one team

Cancer – one word that turns the patients’ world upside down. In addition to uncertainty and fear, they often face an unnerving series of exams and treatments. With its new One-Stop Clinic…

Photo

Article •

Integrated diagnostics and therapy in oncology

Cancer imaging is one of the most promising medical fields. Hybrid technologies, such as PET/CT or future MRI/PET, are the tools radiologists and oncologists use to gain ever deeper insights into the…

Photo

Article •

Multimodality in breast diagnostics and therapy

Early detection currently remains the most promising way to optimise the diagnosis and treatment of breast cancer, lower the mortality rate resulting from this disease, and improve patients' quality…

Related products

Subscribe to Newsletter